Dysregulated RET Signaling in Thyroid Cancer
- 1 June 2008
- journal article
- review article
- Published by Elsevier BV in Endocrinology and Metabolism Clinics of North America
- Vol. 37 (2), 363-374
- https://doi.org/10.1016/j.ecl.2008.02.006
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- The RET Kinase Inhibitor NVP-AST487 Blocks Growth and Calcitonin Gene Expression through Distinct Mechanisms in Medullary Thyroid Cancer CellsCancer Research, 2007
- Enteric nervous system development and Hirschsprung's disease: advances in genetic and stem cell studiesNature Reviews Neuroscience, 2007
- Tyrosine kinase receptor RET is a key regulator of Peyer’s Patch organogenesisNature, 2007
- Absence of Ret Signaling in Mice Causes Progressive and Late Degeneration of the Nigrostriatal SystemPLoS Biology, 2007
- Structure and Chemical Inhibition of the RET Tyrosine Kinase DomainJournal of Biological Chemistry, 2006
- Ablation of Persephin Receptor Glial Cell Line-Derived Neurotrophic Factor Family Receptor α4 Impairs Thyroid Calcitonin Production in Young MiceEndocrinology, 2006
- Autoinhibition ControlScience, 2003
- The GDNF family: Signalling, biological functions and therapeutic valueNature Reviews Neuroscience, 2002
- Molecular Modeling of the Extracellular Domain of the RET Receptor Tyrosine Kinase Reveals Multiple Cadherin-like Domains and a Calcium-binding SitePublished by Elsevier BV ,2001
- Activation of a novel human transforming gene, ret, by DNA rearrangementCell, 1985